{
    "nctId": "NCT02247830",
    "briefTitle": "Management Radiodermatitis in Patients With Breast or Head and Neck Cancer",
    "officialTitle": "Prophylactic Interventions in the Management of Radiodermatitis in Patients With Breast or Head and Neck Cancer: a Randomized Clinical Trial",
    "overallStatus": "COMPLETED",
    "conditions": "Radiodermatitis",
    "studyType": "INTERVENTIONAL",
    "phase": "PHASE3",
    "allocation": "RANDOMIZED",
    "primaryPurpose": "PREVENTION",
    "enrollmentCount": 48,
    "primaryOutcomeMeasure": "Occurrence of radiodermatitis",
    "eligibilityCriteria": "Inclusion Criteria:\n\n* Being an adult, over the age of 18 years old;\n* Owning diagnosis of malignant breast or head and neck;\n* Being first referred to the radiotherapy protocol;\n* Agree to participate, expressing his acceptance by signing the Informed Consent Form (ICF);\n* Present absence of dermatitis to initiation of radiotherapy;\n* Demonstrate understanding of and conditions to continue the intervention in their home environment when needed.\n\nExclusion Criteria:\n\n* Reports of previous hypersensitivity reaction or presentation, during the research, adverse reaction to chamomile or any plant of the Asteraceae or compositae family, or urea;\n* Medical prescription for the procedure of data collection, some kind of intervention to prevent radiodermatitis;\n* Withdrawal of the patient to remain in the study, independent of time.",
    "sex": "ALL",
    "minimumAge": "18 Years",
    "stdAges": "ADULT, OLDER_ADULT"
}